Table 10 Neromuscular effects of mivacurium in paediatric patients in group B (mean ± SD, S)
From: The efficacy and safety of mivacurium in pediatric patients
Subgroups | n | Onset time | T1 5% recovery | T1 25% recovery | Recovery index | TOF ratio 90% |
|---|---|---|---|---|---|---|
Group 5 | 29 | 173 ± 51 | 310 ± 104 | 754 ± 138 | 307 ± 89 | 971 ± 171 |
Group 6 | 25 | 180 ± 56 | 295 ± 95 | 810 ± 150 | 314 ± 78 | 899 ± 215 |
Group 7 | 28 | 184 ± 60 | 300 ± 95 | 805 ± 179 | 296 ± 92 | 979 ± 280 |
Group 8 | 24 | 167 ± 52 | 303 ± 75 | 769 ± 161 | 287 ± 89 | 951 ± 206 |